Halozyme Therapeutics shares owned by Epoch Investment Partners
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Epoch Investment Partners
from 13F filings
Historical chart of Epoch Investment Partners investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Epoch Investment Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Epoch Investment Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $44M | 597k | 73.34 |
| 2025-06-30 | $33M | 632k | 52.02 |
| 2025-03-31 | $53M | 827k | 63.81 |
| 2024-12-31 | $37M | 778k | 47.81 |
| 2024-09-30 | $49M | 853k | 57.24 |
| 2024-06-30 | $75M | 1.4M | 52.36 |
| 2024-03-31 | $58M | 1.4M | 40.68 |
| 2023-12-31 | $43M | 1.2M | 36.96 |
| 2023-09-30 | $13M | 332k | 38.20 |
| 2023-06-30 | $12M | 332k | 36.07 |
| 2023-03-31 | $13M | 332k | 38.19 |
| 2022-12-31 | $11M | 188k | 56.90 |